EMPFIELD JAMES R.

CIK 00016654301 companyBURNABY, A1

SEC Profile

Transactions

Companies

Filings

CIK

0001665430

Recent Transactions

30 trades

Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2024-03-11+65,000→ 65,000 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2023-03-10+75,000→ 75,000 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-08-12$3.10/sh+20,000→ 30,000 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-08-12$38.02/sh−7,257→ 67,743 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2022-08-12−45,000→ 0 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-08-12$38.08/sh−35,868→ 31,875 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-08-12$38.68/sh−21,875→ 10,000 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-08-12$4.75/sh+45,000→ 75,000 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2022-08-12−20,000→ 0 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2022-03-10+65,000→ 65,000 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-03-07$6.76/sh+40,000→ 51,805 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-03-07$30.23/sh−695→ 11,805 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2022-03-07−2,500→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2022-03-07−40,000→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-03-07$8.40/sh+2,500→ 12,500 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-03-07$30.23/sh−8,952→ 42,853 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-03-07$30.54/sh−31,048→ 10,000 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-03-07$30.62/sh−1,805→ 41,048 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-03-04$31.42/sh−6,685→ 28,315 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2022-03-04−25,000→ 0 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-03-04$30.79/sh−18,315→ 10,000 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-03-04$8.40/sh+25,000→ 35,000 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2021-03-12+65,000→ 65,000 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2020-03-12+65,000→ 65,000 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2019-09-16+40,000→ 40,000 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2018-03-12+45,000→ 45,000 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2017-10-23+20,000→ 20,000 total
Purchase
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2017-08-15$2.48/sh+10,000→ 10,000 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2017-03-13+27,500→ 27,500 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2016-02-08+40,000→ 40,000 total

Companies

Xenon Pharmaceuticals Inc.
SVP, Drug Discovery
$XENE

Recent Filings

Address

C/O XENON PHARMACEUTICALS INC. 200 - 3650 GILMORE WAY

BURNABY, A1, V5G 4W8

View on SEC.gov